Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

MGC Pharmaceuticals' proprietary ZAM app "about good practice"

By: News Direct
ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

--News Direct--

MGC Pharmaceuticals Ltd (LSE:MXC, OTC:MGCLF, ASX:MXC) chief commercial officer Robert Clements speaks to Proactive's Thomas Warner after announcing the enrolment of the first patient in its proprietary data collection App and machine learning algorithm, ZAM.

Clements explains why MGC is investing in medical technology, saying that "this is about good practice."

Contact Details

Proactive UK Ltd

+44 20 7989 0813

uk@proactiveinvestors.com

View source version on newsdirect.com: https://newsdirect.com/news/mgc-pharmaceuticals-proprietary-zam-app-about-good-practice-515065995

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  247.31
+0.00 (0.00%)
AAPL  317.31
+0.00 (0.00%)
AMD  534.39
+0.00 (0.00%)
BAC  59.50
+0.00 (0.00%)
GOOG  350.67
+0.00 (0.00%)
META  656.73
+0.00 (0.00%)
MSFT  390.99
+0.00 (0.00%)
NVDA  203.53
+0.00 (0.00%)
ORCL  131.54
+0.00 (0.00%)
TSLA  394.76
+0.00 (0.00%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.